
Innovation in Psychosis Therapeutics Summit
Join leaders at the Innovation in Psychosis Therapeutics Summit to revolutionize psychosis treatment
Newsletters and Deep Dive digital magazine
Join leaders at the Innovation in Psychosis Therapeutics Summit to revolutionize psychosis treatment
PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.
AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.
Join 200+ experts at the 4th ALS Summit to advance biomarkers, targets, and trials for ALS & FTD
London Biotechnology Show Levels Up with Industry Pioneers in Exhibitor Lineup, Hosted Buyer Programme
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks